METHODS AND SYSTEMS FOR ANNOTATING BIOMOLECULAR SEQUENCES
0 Assignments
0 Petitions
Accused Products
Abstract
Polypeptide sequences and polynucleotide sequences are provided. Also provided are annotative information concerning such sequences and uses for these sequences.
-
Citations
57 Claims
-
1-42. -42. (canceled)
-
43. A monoclonal or polyclonal antibody or an antigen binding fragment thereof comprising an antigen binding site that binds specifically to amino acid sequences set forth in any one of SEQ ID NOs:
- 460937, 460949, amino acids residues 327-496 of SED ID NO;
460937, or amino acids residues 327-471 of SED ID NO;
460949. - View Dependent Claims (44, 45, 46, 47, 48, 49, 50)
- 460937, 460949, amino acids residues 327-496 of SED ID NO;
-
51. An assay for detecting the presence of polypeptide comprising the amino acid sequence as set forth in any one of SEQ ID NOs:
- 460937 and 460949 in a biological sample, comprising
contacting the sample with an antibody specific to any one of SEQ ID NOs;
460937, 460949, amino acids residues 327-496 of SED ID NO;
460937, or amino acids residues 327-471 of SED ID NO;
460949, anddetecting the specific binding of said antibody to any one of SEQ ID NOs;
460937, 460949, amino acids residues 327-496 of SED ID NO;
460937, or amino acids residues 327-471 of SED ID NO;
460949 in the sample.
- 460937 and 460949 in a biological sample, comprising
-
52. A method for detecting a cancer, comprising detecting in a subject or in a sample obtained from the subject a polypeptide having a sequence selected from those set forth in any one of SEQ ID NOs:
- 460937 or 460949, wherein a presence of said polypeptide in the subject or in the sample indicates detection of the cancer.
- View Dependent Claims (53, 54, 55, 56, 57)
Specification